コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ditions within 30 days of screening, or were pregnant.
2 2, 2016, we randomly assigned 325 women (215 pregnant, 110 planning pregnancy) to capillary glucose m
3 Results During follow-up, 149 women became pregnant, 131 women had live births, and 16 women had se
4 andomised controlled trial, we recruited non-pregnant adults aged at least 18 years with newly or rec
5 Specifically, peripheral ZIKV infection of pregnant AIR females resulted in detectable virus in bra
6 o capillary glucose monitoring with CGM (108 pregnant and 53 planning pregnancy) or without (107 preg
11 ococcus (GBS), including invasive disease in pregnant and postpartum women, fetal infection/stillbirt
12 3) rats that were allowed to mate and become pregnant and suckled their pups for 21 days before weani
13 but also on how to manage them once they are pregnant and when to refer them to a regional center wit
14 uction of systemic infection and abortion in pregnant animals and provide a viable candidate for the
16 Given that most female cardiologists are pregnant at some point during their careers, particularl
18 as detectable in pregnant WT mice but not in pregnant B-cell knockout dams, and antigen concentration
21 2) rats that were allowed to mate and become pregnant but did not suckle their pups after giving birt
22 ow that small intestine dendritic cells from pregnant, but not from non-pregnant, females secrete IL-
23 Z2 inhibits vertical transmission of ZIKV in pregnant C57BL/6 mice and protects type I or type I/II i
24 sed the timing of birth and fetal outcome in pregnant C57BL/6J mice at 3 months (young) and 5 months
27 viduals, the odds ratio for drug abuse while pregnant compared with an equivalent prepregnancy interv
28 perglycaemic (27% vs 32%; p=0.0279) than did pregnant control participants, with comparable severe hy
31 ciency virus (HIV)-infected women who became pregnant during 2 HIV prevention studies conducted among
32 report here the case of a patient who became pregnant during treatment with ustekinumab for a refract
36 ll transfusions, mortality rates for an ever-pregnant female donor vs male donor were 74 vs 62 per 10
38 R, 0.99 [95% CI, 0.87 to 1.13]); for a never-pregnant female donor vs male donor, mortality rates wer
39 sions, receipt of a transfusion from an ever-pregnant female donor, compared with a male donor, was a
40 to transfusions from ever-pregnant or never-pregnant female donors was analyzed using life tables an
41 ell transfusions from ever-pregnant or never-pregnant female donors, compared with red blood cell tra
43 prevalence of ID among both nonpregnant and pregnant females exist, with Mexican American and non-Hi
46 dritic cells from pregnant, but not from non-pregnant, females secrete IL-1beta, IL-23 and IL-6 and s
49 shment of bacteremia in mice and abortion in pregnant guinea pigs, while complementation of capsule e
50 colleagues discuss viral load monitoring for pregnant HIV-positive women and those breastfeeding; ART
51 etary nitrate supplementation to date in non-pregnant humans and animals, current investigations aim
54 trial at Emory University that enrolled non-pregnant, immunocompetent adults from Atlanta, GA, USA,
55 ct ZIKV inoculation into the uterine wall of pregnant, immunocompetent mice to evaluate transplacenta
56 nancy in Nsanje district, and women who were pregnant in Chikwawa district (and thus not exposed to o
63 the LPA-producing enzyme autotaxin (ATX) in pregnant mice leads to HB-EGF and COX-2 down-regulation
64 the effect of resveratrol supplementation of pregnant mice on offspring thermogenesis and energy expe
69 ected at E12, and reciprocally, treatment of pregnant mice with IFN-lambda2 reduced ZIKV infection.
75 a moderate 30% global calorie restriction of pregnant mothers and used cardiac magnetic resonance ima
76 odevelopmental disorders in the offspring of pregnant mothers undergoing immune system activation owi
80 wild-type (WT) mice were crossed to produce pregnant mouse models with or without adiponectin defici
81 ta on longitudinal changes in iron status in pregnant North American women, emphasizes possible limit
83 a mother who performed farm activities while pregnant (odds ratio, 0.60; 95% CI, 0.48-0.74) and remai
85 e at least 18 years of age, trying to become pregnant or at less than 12 weeks' gestation, not using
86 onpregnant and nonbreastfeeding women and in pregnant or breastfeeding women (OR >49.0; P < 0.001), b
89 ality and exposure to transfusions from ever-pregnant or never-pregnant female donors was analyzed us
91 3000-52000) cases of invasive GBS disease in pregnant or postpartum women, and 57000 (UR, 12000-10400
93 the permeability of cervical mucus from non-pregnant ovulating (n = 20) and high- (n = 9) and low-ri
97 ged, carboxylated microspheres in mucus from pregnant patients was significantly restricted compared
99 -molecule Wnt agonists (Dkk inhibitors) into pregnant Pax9(+/-) mice restored Wnt signaling and led t
101 om a prospective study of incident HIV among pregnant/postpartum women in Kenya were randomly divided
104 Administration of dibutyl phthalate (DBP) to pregnant rats causes reproductive disorders in male offs
106 primary neuronal culture derived from timed pregnant rats in vitro, resulting in a much higher C99 l
112 ical trial that vitamin C supplementation to pregnant smokers can lessen the impact of maternal smoki
114 l patient populations, such as pediatric and pregnant trauma patients, and the potential for future r
115 rticularly maternal farming activities while pregnant, were strongly associated with reduced risk of
117 d through the landscape for up to 50 km, the pregnant woman from Isernia was probably local, given th
118 nd month after primary infection onset in 44 pregnant women (15 transmitting the infection to the fet
119 cy.Nested within a feeding study, 24 healthy pregnant women (26-29 wk of gestation) consumed a single
123 r effect on preterm births among underweight pregnant women (BMI <18.5 kg/m(2); RR 0.84, 95% CI 0.78-
125 in the UK, at 16 fetal medicine centres, of pregnant women aged 16 years or older whose fetus had a
126 crocephaly, in the foetuses and offspring of pregnant women and (b) GBS in any population, and to des
129 nt need to develop pretest education for all pregnant women and consistent post-test management recom
131 ncluding microcephaly in fetuses of infected pregnant women and Guillian-Barre syndrome in adults.
132 rted for other general population samples of pregnant women and nonpregnant adults, was associated wi
133 umulating datasets of genomic information on pregnant women and their fetuses raise ethical issues re
136 from randomisation to 34 weeks' gestation in pregnant women and to 24 weeks or conception in women pl
137 iron supplementation of largely iron-replete pregnant women and young children (6-24 mo) in developed
138 status, current estimates of iron status for pregnant women and young children in the United States a
140 ola, and Zika, are becoming more common, and pregnant women are at increased risk for associated comp
146 Women of reproductive age and particularly pregnant women are the most vulnerable to the adverse co
148 stage growth in vitro is reduced in anaemic pregnant women at baseline, but increased during supplem
149 rth drawn from a prospective birth cohort of pregnant women at Brigham and Women's Hospital in Boston
151 hma Reduction Trial is a randomized trial of pregnant women at risk of having children with asthma ra
152 ra vaccination campaigns have often excluded pregnant women because of insufficient safety data for u
155 MEHP similar to those found in the urine of pregnant women consistently altered hCG and PPARgamma ex
158 to reduce malaria transmission often exclude pregnant women due to safety concerns related to the dru
159 al care providers to provide Tdap vaccine to pregnant women during routine prenatal visits at the ear
160 alciparum pathogenesis in vitro in RBCs from pregnant women during their 2nd and 3rd trimesters.
169 e supplementation in mildly iodine-deficient pregnant women had no effect on child neurodevelopment a
171 intakes in various populations suggest that pregnant women have difficulty meeting all their nutriti
172 immunodeficiency virus research field, where pregnant women have enjoyed better-although imperfect-re
173 ion and one of two on offering disadvantaged pregnant women help to quit smoking that reported on our
176 (DP) to daily TMP-SMX alone in HIV-infected pregnant women in an area of Uganda where indoor residua
177 lined substantially in the 21st century, but pregnant women in areas of sustained transmission still
178 n this randomised, placebo-controlled trial, pregnant women in Bangalore, India, and Bangkok, Thailan
180 ed micronutrient supplementation trial among pregnant women in Dar es Salaam, Tanzania (2001-2004).
181 cific serodiagnostic tests, particularly for pregnant women in dengue virus (DENV)-endemic regions.
182 ve on the risk/benefit tradeoff of including pregnant women in research to address different forms of
183 a community perspective on the inclusion of pregnant women in TB drug research and discuss (1) our p
184 magnetic resonance imaging (MRI) findings in pregnant women in the Department of Diagnostic Imaging,
185 PHIV vs nonperinatally HIV-infected (NPHIV) pregnant women in the Pediatric HIV/AIDS Cohort Study Su
186 cent years, short-term antiviral therapy for pregnant women in the third trimester has been shown to
189 tachment intervention targeting impoverished pregnant women increased more than 2.5-fold when only sh
190 desh, we randomized geographical clusters of pregnant women into individual water treatment, sanitati
191 hain reaction screening of T. cruzi-infected pregnant women is a useful tool for predicting the risk
193 d appropriate treatment of hypothyroidism in pregnant women may be an area for possible prevention of
196 e supplementation in mildly iodine-deficient pregnant women on neurodevelopment of their offspring in
197 rhPAPPA and PAPPA in the serum samples from pregnant women or conditioned medium of trophoblast cell
198 ematologic indexes in otherwise asymptomatic pregnant women or in infants within populations who are
201 o recommend routine iron supplementation for pregnant women or routine screening for iron deficiency
203 uman immunodeficiency virus (HIV)-uninfected pregnant women protected by indoor residual spraying of
204 ng anthropometry for moderately malnourished pregnant women receiving ready-to-use supplemental food
208 rformed a prospective observational study of pregnant women referred to our maternal-fetal medicine d
209 inical need for TB prevention and treatment, pregnant women remain neglected by research initiatives.
211 ngle-center, nonblinded study among selected pregnant women require confirmation in multicenter clini
214 cohort with essentially complete follow-up, pregnant women taking supplemental folic acid at or abov
215 randomized 720 geographical clusters of 5551 pregnant women to a control or an intervention arm.
217 20) and high- (n = 9) and low-risk (n = 16) pregnant women to probes of varying sizes and surface ch
218 s abortion, death, and congenital defects in pregnant women treated with any of the following: 1) a v
219 We found a small difference in HbA1c in pregnant women using CGM (mean difference -0.19%; 95% CI
224 al Asthma Reduction Trial (VDAART), in which pregnant women were randomly assigned to vitamin D suppl
226 s (PASTURE) is a European birth cohort where pregnant women were recruited between August 2002 and Ma
228 interventions, including drug treatment, in pregnant women who are obese or overweight have not had
229 revent or significantly attenuate viremia in pregnant women who are residents of or travelers to epid
230 ernative treatment option for HIV-1-infected pregnant women who are virologically suppressed, in sett
233 mpaign in Tororo, Uganda, among HIV-infected pregnant women who received bed nets, daily trimethoprim
234 d a prospective cohort study in Zambia among pregnant women who received intermittent preventive trea
238 were drawn from a cohort whose partners were pregnant women with a due date between April 25, 2009, a
239 stigated the prevalence of bacteriuria among pregnant women with and without UTI symptoms in Uganda.
240 STF recommends screening for preeclampsia in pregnant women with blood pressure measurements througho
245 Limited data were available in infants and pregnant women with malaria as well as in healthy indivi
247 was conducted in southern Malawi among 1828 pregnant women with moderate malnutrition, defined as a
250 c pathways in murine models and samples from pregnant women with normally grown and large-for-gestati
251 rtain if HCMV DNA in the peripheral blood of pregnant women with primary HCMV infection at the time o
252 CMV-specific T cells by cultured ELISPOT, in pregnant women with primary HCMV infection, in associati
255 Subsequently, eligibility was expanded to pregnant women with sexual partners with similar travel
258 rt a difference in the risk of death between pregnant women with suspected or confirmed EVD compared
261 No therapeutic options are available to pregnant women with ZIKV infection to prevent these effe
263 pecifically, Asian-lineage ZIKV infection of pregnant women's blood led to an exacerbated M2-skewed i
264 Among 56 IPT-DP recipients (26 children, 30 pregnant women) with cardiac parameters, all QTc interva
265 in children younger than 5 years and one in pregnant women), and nine IPT trials (five in children y
269 ects of CQ, its lack of contraindications in pregnant women, and its worldwide availability and low c
270 via Asia, it has become a serious threat to pregnant women, causing microcephaly and other neuropath
273 egies (targeting vaccination for infants, or pregnant women, or prophylactic antibodies for neonates)
274 in New York State for symptomatic patients, pregnant women, their infants, and patients with Guillai
275 togenes causes foodborne systemic disease in pregnant women, which can lead to preterm labor, stillbi
298 d on levels found previously in the urine of pregnant women: mono-n-butyl (MnBP, 200 nM), monobenzyl
299 B compared with term birth in two cohorts of pregnant women: one predominantly Caucasian (n = 39) at
300 lacentar allergen transfer was detectable in pregnant WT mice but not in pregnant B-cell knockout dam
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。